Speculation surrounds GSK's joint venture

16 May 2017 - Deborah Wilkes

Archived

GlaxoSmithKline has declined to comment on recent media reports that it is preparing to acquire the remaining 36.5% stake in its Consumer Healthcare joint venture with Novartis for around GBP8 billion (USD10 billion).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: